Identifying TGFβ1/SMAD3 Targets in Lung Cells
Author Information
Author(s): Zhang Yingze, Handley Daniel, Kaplan Tommy, Yu Haiying, Bais Abha S., Richards Thomas, Pandit Kusum V., Zeng Qilu, Benos Panayiotis V., Friedman Nir, Eickelberg Oliver, Kaminski Naftali
Primary Institution: University of Pittsburgh School of Medicine
Hypothesis
The study aims to identify genome-wide SMAD3 binding targets and the molecular pathways affected by TGFβ1/SMAD3 signaling in lung epithelial cells.
Conclusion
The study identified multiple target genes and pathways affected by TGFβ1/SMAD3 signaling, including the novel target FOXA2.
Supporting Evidence
- The study identified known TGFβ1 target genes like SERPINE1 and SMAD7.
- FOXA2 was confirmed as a novel target of SMAD3.
- Computational approaches revealed multiple pathways affected by TGFβ1/SMAD3 signaling.
- The study utilized both ChIP-on-chip and gene expression microarrays for analysis.
Takeaway
Researchers looked at how a protein called SMAD3 affects other genes in lung cells when stimulated by a factor called TGFβ1, finding new connections that could help us understand lung diseases.
Methodology
The study used chromatin immunoprecipitation combined with microarrays to analyze gene expression and identify SMAD3 binding targets.
Limitations
The findings may not fully represent primary epithelial cells as the study was conducted in A549 cells, which are derived from lung cancer.
Participant Demographics
The study used human A549 lung epithelial carcinoma cells.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website